Onjisaponin BCAS# 35906-36-6 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 35906-36-6 | SDF | Download SDF |
PubChem ID | 21669942 | Appearance | Powder |
Formula | C75H112O35 | M.Wt | 1573.69 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S,3R,4S,4aR,6aR,6bR,8aS,12aS,14aR,14bR)-8a-[(2S,3R,4S,5S,6R)-3-[(2S,3R,4S,5R,6S)-5-[(2S,3R,4R,5R)-3,4-dihydroxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-5-[(E)-3-(4-methoxyphenyl)prop-2-enoyl]oxy-6-methyl-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxycarbonyl-2-hydroxy-6b-(hydroxymethyl)-4,6a,11,11,14b-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid | ||
SMILES | CC1C(C(C(C(O1)OC2C(C(OC(C2OC3C(C(C(C(O3)C)OC4C(C(C(CO4)OC5C(C(C(C(O5)CO)O)O)O)O)O)O)O)OC(=O)C67CCC(CC6C8=CCC9C(C8(CC7)CO)(CCC1C9(CC(C(C1(C)C(=O)O)OC1C(C(C(C(O1)CO)O)O)O)O)C)C)(C)C)C)OC(=O)C=CC1=CC=C(C=C1)OC)O)O)O | ||
Standard InChIKey | QSTBHNPMHXYCII-KJCIHCEPSA-N | ||
Standard InChI | InChI=1S/C75H112O35/c1-30-44(81)48(85)53(90)63(99-30)107-59-58(105-43(80)17-12-33-10-13-34(97-9)14-11-33)32(3)101-67(60(59)108-64-56(93)51(88)57(31(2)100-64)106-62-52(89)47(84)40(28-98-62)104-65-54(91)49(86)45(82)38(26-76)102-65)110-69(96)74-21-20-70(4,5)24-36(74)35-15-16-41-71(6)25-37(79)61(109-66-55(92)50(87)46(83)39(27-77)103-66)73(8,68(94)95)42(71)18-19-72(41,7)75(35,29-78)23-22-74/h10-15,17,30-32,36-42,44-67,76-79,81-93H,16,18-29H2,1-9H3,(H,94,95)/b17-12+/t30-,31-,32+,36-,37-,38+,39+,40+,41+,42+,44-,45-,46+,47-,48+,49-,50-,51-,52+,53+,54+,55+,56+,57-,58-,59-,60+,61-,62-,63-,64-,65-,66-,67-,71+,72+,73-,74-,75-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Onjisaponin B induces autophagy via the AMPK-mTOR signaling pathway, increases the NGF level and accelerates both the removal of mutant huntingtin and A53T α-synuclein, it may have potential therapeutic effects on Parkinson disease, Alzheimer disease and Huntington disease. Onjisaponins may provide safe and potent adjuvants for intranasal inoculation of influenza HA and DPT vaccines. |
Targets | AMPK | mTOR | PGE | TNF-α | NGF |
In vitro | Onjisaponin B derived from Radix Polygalae enhances autophagy and accelerates the degradation of mutant α-synuclein and huntingtin in PC-12 cells.[Pubmed: 24248062]Int J Mol Sci. 2013 Nov 15;14(11):22618-41.Emerging evidence indicates important protective roles being played by autophagy in neurodegenerative disorders through clearance of aggregate-prone or mutant proteins. The gastrointestinal irritation of polygala saponins and its potential mechanism in vitro and in vivo.[Pubmed: 25705699]Biomed Res Int. 2015;2015:918048.Processing alters the pharmacological activity and reduces the gastrointestinal toxicity of the polygalae. |
Onjisaponin B Dilution Calculator
Onjisaponin B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 0.6354 mL | 3.1772 mL | 6.3545 mL | 12.709 mL | 15.8862 mL |
5 mM | 0.1271 mL | 0.6354 mL | 1.2709 mL | 2.5418 mL | 3.1772 mL |
10 mM | 0.0635 mL | 0.3177 mL | 0.6354 mL | 1.2709 mL | 1.5886 mL |
50 mM | 0.0127 mL | 0.0635 mL | 0.1271 mL | 0.2542 mL | 0.3177 mL |
100 mM | 0.0064 mL | 0.0318 mL | 0.0635 mL | 0.1271 mL | 0.1589 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Boc-His(Tos)-OH
Catalog No.:BCC3402
CAS No.:35899-43-5
- Ligustroside
Catalog No.:BCN5310
CAS No.:35897-92-8
- Boc-Arg-OH.HCl.H2O
Catalog No.:BCC3053
CAS No.:35897-34-8
- Vestitol
Catalog No.:BCN5309
CAS No.:35878-41-2
- Novokinin
Catalog No.:BCC6051
CAS No.:358738-77-9
- Apocynol A
Catalog No.:BCN4642
CAS No.:358721-33-2
- H-Trp-OBzl.HCl
Catalog No.:BCC3113
CAS No.:35858-81-2
- Etazolate hydrochloride
Catalog No.:BCC6648
CAS No.:35838-58-5
- 3-Epicabraleahydroxylactone
Catalog No.:BCN5308
CAS No.:35833-72-8
- Cabraleahydroxylactone acetate
Catalog No.:BCN5307
CAS No.:35833-70-6
- Cabraleahydroxylactone
Catalog No.:BCN5306
CAS No.:35833-69-3
- Cabraleadiol 3-acetate
Catalog No.:BCN5305
CAS No.:35833-62-6
- 3,3-Dimethoxy-5α-androstan-17-one
Catalog No.:BCC8594
CAS No.:3591-19-3
- Pteroside A
Catalog No.:BCN8146
CAS No.:35910-15-7
- Pterosin A
Catalog No.:BCN8147
CAS No.:35910-16-8
- NECA
Catalog No.:BCC5804
CAS No.:35920-39-9
- Vicenin -1
Catalog No.:BCN3012
CAS No.:35927-38-9
- Pterosin C
Catalog No.:BCN7104
CAS No.:35938-43-3
- Triciribine
Catalog No.:BCC3872
CAS No.:35943-35-2
- Pteroside D
Catalog No.:BCN5311
CAS No.:35943-38-5
- Anchustrigosine
Catalog No.:BCC8185
CAS No.:
- 3-Hydroxy-11-ursen-28,13-olide
Catalog No.:BCN5312
CAS No.:35959-05-8
- 3-Acetoxy-11-ursen-28,13-olide
Catalog No.:BCN5313
CAS No.:35959-08-1
- Inotodiol
Catalog No.:BCN3331
CAS No.:35963-37-2
The gastrointestinal irritation of polygala saponins and its potential mechanism in vitro and in vivo.[Pubmed:25705699]
Biomed Res Int. 2015;2015:918048.
Processing alters the pharmacological activity and reduces the gastrointestinal toxicity of the polygalae. To investigate the effect of processing, different glycosyl substituent products were tested. Hypnotic and subhypnotic doses of pentobarbital-induced sleep tests on mice were used to evaluate the sedative activity of polygala saponins with different glycosyl substituents; isolated gut motility experiment was employed to study excitatory effects of different polygala saponins; the gastrointestinal irritation effects of different polygala saponins were compared by measuring the levels of gastric PGE2 and intestinal TNF-alpha on mice. When compared with control, Onjisaponin B (OJB) and tenuifolin (TEN), but not senegenin (SNG), significantly increased the number of sleeping mice and prolonged the sleeping time (P < 0.05); 80, 40, and 20 mg/L of OJB and 80 mg/L of TEN, but not SNG, obviously changed the amplitude and frequency of isolated jejunum (P < 0.05); all the three compounds significantly decreased the level of gastric PGE2 but had no obvious influences on the reduction of intestinal TNF-alpha level. For sedative and hypnotic effects, OJB > TEN > SNG; for the protection form gastrointestinal irritation and damages, OJB > TEN > SNG. Therefore, in processing Polygala, glycosyl breaking may be related to the decline of pharmacological activity and gastrointestinal toxicity of polygala saponins.
Onjisaponin B derived from Radix Polygalae enhances autophagy and accelerates the degradation of mutant alpha-synuclein and huntingtin in PC-12 cells.[Pubmed:24248062]
Int J Mol Sci. 2013 Nov 15;14(11):22618-41.
Emerging evidence indicates important protective roles being played by autophagy in neurodegenerative disorders through clearance of aggregate-prone or mutant proteins. In the current study, we aimed to identify autophagy inducers from Chinese medicinal herbs as a potential neuroprotective agent that enhances the clearance of mutant huntingtin and alpha-synuclein in PC-12 cells. Through intensive screening using the green fluorescent protein-light chain 3 (GFP-LC3) autophagy detection platform, we found that the ethanol extracts of Radix Polygalae (Yuan Zhi) were capable of inducing autophagy. Further investigation showed that among three single components derived from Radix Polygalae--i.e., polygalacic acid, senegenin and Onjisaponin B--Onjisaponin B was able to induce autophagy and accelerate both the removal of mutant huntingtin and A53T alpha-synuclein, which are highly associated with Huntington disease and Parkinson disease, respectively. Our study further demonstrated that Onjisaponin B induces autophagy via the AMPK-mTOR signaling pathway. Therefore, findings in the current study provide detailed insights into the protective mechanism of a novel autophagy inducer, which is valuable for further investigation as a new candidate agent for modulating neurodegenerative disorders through the reduction of toxicity and clearance of mutant proteins in the cellular level.